---
title: "Michael Burry targets Pfizer, Molina, Halliburton as inflation hedge"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286619269.md"
description: "Michael Burry has invested in Pfizer, Molina Healthcare, and Halliburton, citing their earnings stability and inflation resilience. Pfizer provides a high dividend and strong drug pipeline, Molina is expected to recover, and Halliburton benefits from rising oil prices. However, a potential recession poses risks, although current valuations suggest limited downside."
datetime: "2026-05-15T21:37:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286619269.md)
  - [en](https://longbridge.com/en/news/286619269.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286619269.md)
---

# Michael Burry targets Pfizer, Molina, Halliburton as inflation hedge

Burry’s new picks: Michael Burry bought Pfizer, Molina Healthcare, and Halliburton for their earnings stability, pricing power, and inflation resilience. Sector advantages: Pfizer offers a high dividend and drug pipeline, Molina stands to rebound post-trough year, and Halliburton gains from oil price recovery. Risks ahead: A recession could pressure all three stocks, but valuations already reflect significant downside risk.

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MOH.US](https://longbridge.com/en/quote/MOH.US.md)
- [HAL.US](https://longbridge.com/en/quote/HAL.US.md)
- [IEZ.US](https://longbridge.com/en/quote/IEZ.US.md)
- [XES.US](https://longbridge.com/en/quote/XES.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [CURE.US](https://longbridge.com/en/quote/CURE.US.md)
- [OIH.US](https://longbridge.com/en/quote/OIH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [XOP.US](https://longbridge.com/en/quote/XOP.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis](https://longbridge.com/en/news/286344524.md)
- [European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors | PFE Stock News](https://longbridge.com/en/news/286244385.md)
- [Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer](https://longbridge.com/en/news/286087618.md)
- [Pfizer Inc. $PFE Stock Holdings Boosted by Canada Post Corp Registered Pension Plan](https://longbridge.com/en/news/286666435.md)
- [Pfizer receives EC approval for Hympavzi to treat haemophilia](https://longbridge.com/en/news/286405850.md)